Alphinity Investment Management Pty LTD Bristol Myers Squibb CO Transaction History

Alphinity Investment Management Pty LTD

  • $16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 06, 2019
SELL
$44.62 - $49.34 $13.7 Million - $15.1 Million
-306,439 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$45.12 - $53.8 $2.45 Million - $2.93 Million
-54,391 Reduced 15.07%
306,439 $14.6 Million
Q4 2018

Feb 13, 2019
BUY
$48.76 - $63.23 $17.6 Million - $22.8 Million
360,830 New
360,830 $18.8 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alphinity Investment Management Pty LTD Portfolio

Follow Alphinity Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphinity Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alphinity Investment Management Pty LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email